The BEACON study tested both a doublet and a triplet of drugs for patients with previously treated BRAF V600E–mutated metastatic colorectal cancer (CRC). This means that the increased toxicity from ...

Significant strides have been made in the frontline treatment of patients with advanced clear cell renal cell carcinoma (ccRCC). There are multiple standard-of-care doublet regimens consisting of ...

Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma Treatment with the triplet regimen of ...

For men with metastatic castration-sensitive prostate cancer (mCSPC), a combination of three drugs may not always be better than two drugs, say researchers. Contemporary androgen deprivation therapy ...

Enrollment for a randomized phase 2 trial designed to compare a triplet regimen and doublet regimen for certain patients with leukemia has been discontinued due to low likelihood of benefit. The ...

At the 2020 European Society for Medical Oncology (ESMO) virtual congress, researchers presented results for safety and efficacy of olaparib plus durvalumab with or without bevacizumab in women with ...

Please provide your email address to receive an email when new articles are posted on . Cabozantinib plus nivolumab and ipilimumab conferred a significant PFS benefit vs. nivolumab and ipilimumab ...

New data on treatment for newly diagnosed pulmonary arterial hypertension (PAH) show initial treatment for the progressive disease that includes macitentan has potential to reduce risk of disease ...

NEW ORLEANS -- A three-drug regimen should be the standard for graft-versus-host disease (GvHD) prophylaxis in blood cancer patients undergoing reduced-intensity conditioning allogeneic hematopoietic ...